Disc Medicine Appoints Lisa Amaya Price, MBA as Chief Human Resources Officer

Core Viewpoint - Disc Medicine, Inc. has appointed Lisa Amaya Price as Chief Human Resources Officer to support the company's growth and commercialization efforts in the biopharmaceutical sector [1][2]. Group 1: Appointment and Role - Lisa Amaya Price brings over 25 years of experience in human resources and organizational leadership from various commercial-stage companies [1][2]. - The company aims to build a strong, scalable organization by attracting and retaining exceptional talent, with Ms. Amaya Price playing a central role in this initiative [2]. Group 2: Ms. Amaya Price's Background - Prior to joining Disc Medicine, Ms. Amaya Price served as SVP and Chief HR Officer at Deciphera, where she led the integration into ONO Pharmaceuticals [2]. - She has held senior HR leadership positions at LGC Group, Scholar Rock, and Takeda Pharmaceuticals, where she was involved in organizational design and talent selection [2]. Group 3: Inducement Equity Award - On January 12, 2026, Disc granted Ms. Amaya Price an inducement equity award consisting of an option to purchase 37,500 shares, a restricted stock unit award for 25,000 shares, and a supplemental restricted stock unit award for 4,000 shares [3]. - The vesting schedule for the awards includes 25% vesting on January 12, 2027, with the remainder vesting in monthly installments, and the RSU awards vesting in equal installments over four years [3]. Group 4: Company Overview - Disc Medicine is a clinical-stage biopharmaceutical company focused on developing novel treatments for serious hematologic diseases, targeting fundamental biological pathways related to red blood cell biology [4].